Skip to content

Tufik Ramzi Assad, M.D.

NPI 1093941890ActiveIndividual· Internal Medicine, Pulmonary Disease· Boston, MA

Internal Medicine, Pulmonary Disease (M.D.) in Boston, Massachusetts, trained at Medical College of Georgia School of Medicine (class of 2009). Their prescriptions cost Medicare Part D more than their services did: $2,241,082 for 2,246 claims, against $173,503 paid for services in 2024. Glaxosmithkline, LLC. was the largest of 19 companies reporting payments in 2025, $836.50 in all, mostly food and beverage.

Overview

NPI1093941890
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJun 8, 2009
Last updated in NPPESDec 31, 2015

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Pulmonary Disease Primary207RP1001X53507TN

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pulmonary Disease (TN)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients606
Services billed2,110 across 51 procedure codes
Paid by Medicare$173,503

Part D prescriptions in 2024

Prescriptions (claims)2,246 · 2,790 30-day fills
Patients362
Total drug cost$2,241,082
Generic share39% of claims

Medicare sources and data years

Education and affiliations

Medical schoolMedical College of Georgia School of Medicine
Graduation year2009
Medicare specialtyPulmonary Disease
Secondary specialtiesInternal Medicine
TelehealthOffers telehealth

Medical group

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$836.50 · 39 payments from 19 companies
  • 2024$9,539 · 33 payments from 14 companies

Top paying companies in 2025

CompanyAmountPayments
Glaxosmithkline, LLC.$160.0814
Ethicon Inc.$84.233
Csl Behring$77.533
Insmed, Inc.$60.672
Jazz Pharmaceuticals Inc.$57.932

What the 2025 payments were for

  • Food and Beverage$836.50 · 39 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Pulmonary Disease providers in Boston

All Internal Medicine, Pulmonary Disease providers in Massachusetts →